USC.edu
Are You a Patient?

Emily M. Hsieh

Assistant Professor of Clinical Pediatrics

Image of Emily M. Hsieh
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Publications

  • CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review. Blood Adv. 2026 May 26; 10(10):3467-3479.. View in PubMed
  • Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis. Blood Adv. 2025 Nov 11; 9(21):5489-5500.. View in PubMed
  • Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group. Transplant Cell Ther. 2026 Mar; 32(3):261-276.. View in PubMed
  • Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood Adv. 2025 Oct 28; 9(20):5249-5262.. View in PubMed
  • Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology. 2025 Oct 07; 105(7):e214086.. View in PubMed
  • Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia. Blood. 2025 Jul 24; 146(4):437-455.. View in PubMed
  • Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal. Elife. 2025 Apr 10; 13.. View in PubMed
  • Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal. bioRxiv. 2025 Feb 19.. View in PubMed
  • Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults. Blood Adv. 2024 07 09; 8(13):3544-3548.. View in PubMed
  • INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities. Transplant Cell Ther. 2024 01; 30(1):38-55.. View in PubMed

Similar People